West Pharma (WST) Reports Q3 EPS of $0.44
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $349.16 +1.43%
Revenue Growth %: +2.5%
Financial Fact:
Net sales: 376.7M
Today's EPS Names:
ANAB, ANIX, MNY, More
Revenue Growth %: +2.5%
Financial Fact:
Net sales: 376.7M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q3 EPS of $0.44, versus $0.44 reported last year. Revenue for the quarter came in at $344.5 million, versus $355.9 million reported last year.
West Pharma sees FY2015 EPS of $1.79-$1.84.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
- Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
- RH (RH) Tops Q2 EPS by $2.31
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
